Stocks · Health care · Pharmaceutical Preparations

Ovid Therapeutics Inc.

OVID Clue Score44
United States Fiscal year ends December CIK 0001636651 Results filed 18 Mar 2026

What the insiders did Net selling

By person

8 insiders · 3 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Margaret A. Alexander
President and CEO
—
$16.90K (1)
−$16.90K
61,750
$89.54K
+119.6%
Jeffrey A Rona
Cbfo
—
$12.38K (1)
−$12.38K
156,313
$226.65K
+174.8%
Takeda Pharmaceutical Co Ltd entity
10% owner
—
—
—
7,000,000
$10.15M
+21.7%
Jeremy M Levin
Executive Chairman
—
—
—
3,735,048
$5.42M
+3.3%
Stelios Papadopoulos
Director
—
—
—
217,578
$315.49K
+8.8%
Charles Ross Carter
Chief Financial Officer
—
—
—
94,375
$136.84K
+112.7%
Kevin Joseph Fitzgerald
Director
—
—
—
17,578
$25.49K
—
Bart Friedman
Director
—
—
—
8,789
$12.74K
—

No percentages here. This company's share count has moved by a factor of 2.7 over the window, from 71,109,514 to 195,297,857 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.